Chargement en cours...
Management of hair loss associated with endocrine therapy in patients with breast cancer: an overview
Endocrine therapy-induced hair loss (ETIHL) associated with aromatase inhibitors and tamoxifen treatment is currently mostly reported but remained an unresolved therapeutic issue in patients with breast cancer (BC) since the number of studies regarding the management is limited in literature. Herein...
Enregistré dans:
| Publié dans: | Springerplus |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Springer International Publishing
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4864803/ https://ncbi.nlm.nih.gov/pubmed/27247882 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40064-016-2216-3 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|